Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma Retreated with Daratumumab in Real-World Clinical Practice in the USA

被引：0
|
作者：
Ailawadhi, Sikander [1 ]
Larson, Sarah M. [2 ]
Ferrante, Shannon [3 ]
Rafalko, Nicole [4 ,5 ]
Gupta-Werner, Niodita [5 ]
Harper, Jennifer S. [3 ]
Medhekar, Rohan [5 ]
Armoon, Marjohn [6 ]
Cortoos, Annelore [7 ]
Kaila, Shuchita [5 ]
Atrash, Shebli [8 ]
机构：
[1] Mayo Clin Florida, Div Hematol Oncol, Jacksonville, FL USA
[2] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
[3] Janssen Sci Affairs LLC, Titusville, NJ USA
[4] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA USA
[5] Janssen Sci Affairs LLC, Horsham, PA USA
[6] Janssen Sci Affairs LLC, Multiple Myeloma, Hematol US Med Affairs, Horsham, PA USA
[7] Janssen Sci Affairs LLC, Horsham, PA USA
[8] Levine Canc Inst, Charlotte, NC USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-199085
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2381 / 2382
页数：2
相关论文
共 50 条
  • [31] Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
    Lovas, Szilvia
    Varga, Gergely
    Farkas, Peter
    Masszi, Tamas
    Wohner, Nikolett
    Bereczki, Agnes
    Adamkovich, Nora
    Borbenyi, Zita
    Szomor, Arpad
    Alizadeh, Hussain
    Szaleczky, Erika
    Wolf, Krisztina
    Schneider, Tamas
    Plander, Mark
    Szendrei, Tamas
    Csacsovszki, Otto
    Csukly, Zoltan
    Rajnics, Peter
    Egyed, Miklos
    Nagy, Zsolt
    Rejto, Laszlo
    Illes, Arpad
    Mikala, Gabor
    Varoczy, Laszlo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (05) : 559 - 565
  • [32] Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England
    Moore, Sally
    Cornic, Laura
    Crossman-Barnes, Christina-Jane
    Jose, Sophie
    Khalaf, Zeyad
    Yong, Kwee
    Soutar, Megan
    Woods, Philip
    EJHAEM, 2025, 6 (01):
  • [33] Pattern of Use and Outcomes of Daratumumab Therapy in Patients with Multiple Myeloma in a Real-World Setting: A Single Institution Experience
    Dima, Danai
    Hu, Xiao
    Dower, Joshua
    Comenzo, Raymond L.
    Varga, Cindy
    BLOOD, 2020, 136
  • [34] Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
    Varughese, Prateesh
    Smith, Robert
    Xue, Mei
    Dorrow, Natalie
    Hogea, Cosmina
    Maiese, Eric. M.
    Buckingham, Trudy
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (01) : 65 - 74
  • [35] Real-World Treatment Patterns and Outcomes of Patients with Functional High-Risk (Early Relapse) Multiple Myeloma
    Belli, Andrew J.
    Hansen, Eric
    Kansagra, Ankit
    Dilwali, Keshava
    Wang, Ching-Kun
    BLOOD, 2020, 136
  • [36] Real-world duration of use and dosing frequency of daratumumab in patients with multiple myeloma in the US
    Fonseca, Rafael
    Chinaeke, Eric
    Gupta, Niodita
    Fu, Alex
    Ran, Tao
    Kaila, Shuchita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S144 - S145
  • [37] Real-World Disparities in Daratumumab Utilization for Patients with Relapsed or Refractory Multiple Myeloma (MM)
    Maignan, Kathleen
    Backenroth, Daniel
    McQuarrie, Neil A.
    Lipitz, Nicole G.
    Williams, Erin R.
    Carson, Kenneth R.
    BLOOD, 2018, 132
  • [38] Real-World Patient Characteristics and Treatment Outcomes Among Newly Diagnosed Multiple Myeloma Patients Initiating Daratumumab, Lenalidomide, and Dexamethasone As First-Line Therapy
    Tai, Ming-Hui
    Cai, Qian
    Fu, Alex Z.
    Khare, Vipin
    Kaila, Shuchita
    BLOOD, 2021, 138 : 1979 - +
  • [39] DARATUMUMAB AS A COMBINATION TREATMENT IN PATIENTS WITH RELAPSING MULTIPLE MYELOMA: REAL LIFE OUTCOMES
    Perez Montana, A.
    Sanchez Raga, J. M.
    Beltran Serra, N.
    Ros Mateu, T.
    Sampol Mayol, A.
    HAEMATOLOGICA, 2018, 103 : 118 - 119
  • [40] Real-world clinical outcomes and treatment patterns among patients with triple-class exposed multiple myeloma: an analysis using the Connect® multiple myeloma disease registry
    Lee, Hans
    Ailawadhi, Sikander
    Dhanda, Devender
    Patwardhan, Pallavi
    Yu, Edward
    Liu, Liang
    Rifkin, Robert
    Terebelo, Howard
    Abonour, Rafat
    Narang, Mohit
    Gasparetto, Cristina
    Toomey, Kathleen
    Hardin, James
    Durie, Brian
    Jagannath, Sundar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S193 - S194
12345